Bank of America’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,004,900
| Closed | -$102M | – | 8108 |
|
|
2025
Q3 | $102M | Buy |
4,004,900
+827,800
| +26% | +$20.4M | 0.01% | 1191 |
|
|
2025
Q2 | $77M | Sell |
3,177,100
-3,458,200
| -52% | -$80.6M | 0.01% | 1345 |
|
|
2025
Q1 | $168M | Buy |
6,635,300
+3,629,900
| +121% | +$95M | 0.01% | 799 |
|
|
2024
Q4 | $79.7M | Sell |
3,005,400
-46,000
| -2% | -$1.25M | 0.01% | 1186 |
|
|
2024
Q3 | $88.3M | Buy |
3,051,400
+1,693,600
| +125% | +$49.4M | 0.01% | 1143 |
|
|
2024
Q2 | $38M | Sell |
1,357,800
-605,200
| -31% | -$16.7M | ﹤0.01% | 1665 |
|
|
2024
Q1 | $54.5M | Sell |
1,963,000
-256,000
| -12% | -$7.1M | ﹤0.01% | 1418 |
|
|
2023
Q4 | $63.9M | Buy |
2,219,000
+81,500
| +4% | +$2.46M | 0.01% | 1195 |
|
|
2023
Q3 | $70.9M | Buy |
2,137,500
+986,000
| +86% | +$34.9M | 0.01% | 1073 |
|
|
2023
Q2 | $42.2M | Sell |
1,151,500
-820,800
| -42% | -$31.9M | ﹤0.01% | 1441 |
|
|
2023
Q1 | $80.5M | Sell |
1,972,300
-1,702,200
| -46% | -$73.5M | 0.01% | 1061 |
|
|
2022
Q4 | $188M | Sell |
3,674,500
-270,400
| -7% | -$13M | 0.02% | 616 |
|
|
2022
Q3 | $173M | Buy |
3,944,900
+2,047,700
| +108% | +$99.5M | 0.02% | 631 |
|
|
2022
Q2 | $99.5M | Buy |
1,897,200
+1,457,700
| +332% | +$74.3M | 0.01% | 885 |
|
|
2022
Q1 | $22.8M | Sell |
439,500
-1,691,900
| -79% | -$87.8M | ﹤0.01% | 2033 |
|
|
2021
Q4 | $126M | Sell |
2,131,400
-704,100
| -25% | -$34.9M | 0.01% | 892 |
|
|
2021
Q3 | $122M | Buy |
2,835,500
+2,009,500
| +243% | +$89M | 0.01% | 858 |
|
|
2021
Q2 | $32.3M | Buy |
826,000
+233,500
| +39% | +$9.08M | ﹤0.01% | 1701 |
|
|
2021
Q1 | $21.5M | Buy |
592,500
+581,900
| +5,490% | +$20.7M | ﹤0.01% | 1973 |
|
|
2020
Q4 | $390K | Sell |
10,600
-1,532,878
| -99% | -$56.2M | ﹤0.01% | 5168 |
|
|
2020
Q3 | $53.7M | Buy |
1,543,478
+1,052,103
| +214% | +$36.9M | 0.01% | 1041 |
|
|
2020
Q2 | $15.2M | Buy |
491,375
+211,749
| +76% | +$7.19M | ﹤0.01% | 1831 |
|
|
2020
Q1 | $8.66M | Sell |
279,626
-904,332
| -76% | -$30.8M | ﹤0.01% | 2183 |
|
|
2019
Q4 | $44M | Sell |
1,183,958
-447,529
| -27% | -$15.9M | 0.01% | 1266 |
|
|
2019
Q3 | $55.6M | Buy |
1,631,487
+789,552
| +94% | +$28.7M | 0.01% | 1052 |
|
|
2019
Q2 | $34.6M | Sell |
841,935
-196,887
| -19% | -$7.82M | 0.01% | 1398 |
|
|
2019
Q1 | $41.9M | Buy |
1,038,822
+10,961
| +1% | +$439K | 0.01% | 1239 |
|
|
2018
Q4 | $42.6M | Buy |
1,027,861
+160,524
| +19% | +$6.66M | 0.01% | 1108 |
|
|
2018
Q3 | $36.3M | Sell |
867,337
-437,515
| -34% | -$16.8M | 0.01% | 1335 |
|
|
2018
Q2 | $44.9M | Buy |
1,304,852
+210,273
| +19% | +$7.19M | 0.01% | 1161 |
|
|
2018
Q1 | $36.9M | Sell |
1,094,579
-2,148,263
| -66% | -$73.9M | 0.01% | 1275 |
|
|
2017
Q4 | $111M | Buy |
3,242,842
+206,057
| +7% | +$7.03M | 0.02% | 681 |
|
|
2017
Q3 | $103M | Buy |
3,036,785
+623,230
| +26% | +$20M | 0.02% | 747 |
|
|
2017
Q2 | $76.9M | Sell |
2,413,555
-3,045,849
| -56% | -$96.1M | 0.02% | 813 |
|
|
2017
Q1 | $177M | Buy |
5,459,404
+260,444
| +5% | +$8.21M | 0.04% | 452 |
|
|
2016
Q4 | $160M | Sell |
5,198,960
-673,823
| -11% | -$20.6M | 0.03% | 471 |
|
|
2016
Q3 | $189M | Buy |
5,872,783
+330,640
| +6% | +$11.1M | 0.04% | 413 |
|
|
2016
Q2 | $185M | Buy |
5,542,143
+2,059,411
| +59% | +$65.7M | 0.04% | 409 |
|
|
2016
Q1 | $97.9M | Buy |
3,482,732
+183,290
| +6% | +$5.24M | 0.02% | 615 |
|
|
2015
Q4 | $101M | Sell |
3,299,442
-10,865,791
| -77% | -$342M | 0.02% | 644 |
|
|
2015
Q3 | $422M | Buy |
14,165,233
+5,421,881
| +62% | +$174M | 0.11% | 208 |
|
|
2015
Q2 | $278M | Buy |
8,743,352
+5,148,369
| +143% | +$168M | 0.09% | 253 |
|
|
2015
Q1 | $119M | Sell |
3,594,983
-2,306,363
| -39% | -$73.3M | 0.04% | 450 |
|
|
2014
Q4 | $174M | Sell |
5,901,346
-4,367,671
| -43% | -$125M | 0.06% | 356 |
|
|
2014
Q3 | $288M | Sell |
10,269,017
-629,448
| -6% | -$17.7M | 0.09% | 228 |
|
|
2014
Q2 | $307M | Sell |
10,898,465
-259,811
| -2% | -$7.41M | 0.1% | 215 |
|
|
2014
Q1 | $340M | Buy |
11,158,276
+6,485,051
| +139% | +$193M | 0.13% | 177 |
|
|
2013
Q4 | $136M | Buy |
4,673,225
+719,460
| +18% | +$20.9M | 0.05% | 394 |
|
|
2013
Q3 | $108M | Sell |
3,953,765
-23,857,501
| -86% | -$649M | 0.04% | 438 |
|
|
2013
Q2 | $739M | Buy |
+27,811,266
| New | +$768M | 0.31% | 62 |
|
Other funds holding PFE
VCM
VPM
Bank of America's PFE Position: Q1 2026 in Review
Bank of America reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $59.5M and leaving 46,545,479 shares worth $1.31B. The position accounts for 0.1% of the portfolio, ranked #200.
Bank of America first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.79B in Q3 2017. 2,947 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of America held 46,545,479 shares of Pfizer worth $1.31B as of Q1 2026.
- Bank of America sold 2,235,713 Pfizer shares in Q1 2026, an estimated $59.5M.
- Pfizer made up 0.1% of Bank of America's portfolio in Q1 2026, its #200 holding.
- Bank of America first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Pfizer position peaked at $4.79B in Q3 2017.
- 2,947 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.